Keywords: satraplatin, cuts, pain, psa, level, ph, iii

Satraplatin cuts Pain and PSA level at Ph III

Article | 02 April 2007

Print This

USA-based drugmaker Pharmion and Germany's GPC Biotech say that data from a Phase III trial of satraplatin, an anticancer drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in